• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体器官移植中抗真菌预防的当前趋势:来自欧洲临床微生物与感染病学会-欧洲真菌病研究小组、欧洲临床微生物与感染病学会-欧洲重症监护病房感染学会、意大利移植学会以及西班牙医学传染病学会-西班牙移植感染研究与干预协作组的一项研究

Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC.

作者信息

Salmanton-García Jon, Giacinta Alessandro, Giannella Maddalena, Vena Antonio, Muñoz Patricia, Cornely Oliver A, Valerio Maricela

机构信息

Institute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Herderstraße 52, 50931, Cologne, Germany.

University Hospital Cologne, Cologne, Germany.

出版信息

Infection. 2025 Jul 4. doi: 10.1007/s15010-025-02575-z.

DOI:10.1007/s15010-025-02575-z
PMID:40614031
Abstract

INTRODUCTION

Invasive fungal diseases (IFD) present serious risks to solid organ transplant recipients, particularly in the first 180 days post-transplant. Existing European and US guidelines offer limited evidence, prompting a shift away from universal prophylaxis due to adverse effects, drug-interactions, and costs. This study investigates antifungal prophylaxis practices in transplant centers to guide IFD management.

METHODS

From May 2023 to May 2024, tertiary care institutions completed an online survey on antifungal prophylaxis post-transplant. Data included transplant volumes, IFD incidence by pathogen, and prophylactic strategies.

RESULTS

Responses from 64 centers in 32 countries, mainly in Europe, highlighted kidney and liver as the most common transplants. Prophylaxis was universal in lung transplants and common in liver, bowel, and heart transplants, often triggered by reintervention or Candida spp. colonization. Preferred agents included liposomal amphotericin B and fluconazole.

CONCLUSIONS

This global survey reveals substantial variation in antifungal prophylaxis practices among solid organ transplant centers, driven by a lack of standardized, evidence-based guidelines. Our findings underscore the urgent need for harmonized recommendations that reflect evolving fungal epidemiology, improved diagnostics, and new antifungal agents.

摘要

引言

侵袭性真菌病(IFD)对实体器官移植受者构成严重风险,尤其是在移植后的前180天。现有的欧洲和美国指南提供的证据有限,由于不良反应、药物相互作用和成本等因素,促使人们不再采用普遍预防措施。本研究调查了移植中心的抗真菌预防措施,以指导IFD的管理。

方法

2023年5月至2024年5月,三级医疗机构完成了一项关于移植后抗真菌预防的在线调查。数据包括移植量、按病原体分类的IFD发病率以及预防策略。

结果

来自32个国家(主要是欧洲)的64个中心的回复显示,肾脏和肝脏移植是最常见的移植类型。肺移植普遍采用预防措施,肝脏、肠道和心脏移植也较为常见,通常是由再次干预或念珠菌属定植引发的。首选药物包括脂质体两性霉素B和氟康唑。

结论

这项全球调查显示,由于缺乏标准化的循证指南,实体器官移植中心的抗真菌预防措施存在很大差异。我们的研究结果强调迫切需要统一的建议,以反映不断变化的真菌流行病学、改进的诊断方法和新的抗真菌药物。

相似文献

1
Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC.实体器官移植中抗真菌预防的当前趋势:来自欧洲临床微生物与感染病学会-欧洲真菌病研究小组、欧洲临床微生物与感染病学会-欧洲重症监护病房感染学会、意大利移植学会以及西班牙医学传染病学会-西班牙移植感染研究与干预协作组的一项研究
Infection. 2025 Jul 4. doi: 10.1007/s15010-025-02575-z.
2
Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.开发和验证一种风险模型,用于识别非中性粒细胞减少、危重症成年患者侵袭性念珠菌感染的高危人群:真菌感染风险评估(FIRE)研究。
Health Technol Assess. 2013 Feb;17(3):1-156. doi: 10.3310/hta17030.
3
Correction: Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC.更正:实体器官移植中抗真菌预防的当前趋势:一项来自欧洲临床微生物与感染性疾病学会-欧洲真菌病研究组(ESCMID-EFISG)、欧洲临床微生物与感染性疾病学会-欧洲重症监护感染学会(ESCMID-ESGICH)、意大利移植学会(SITA)以及西班牙医学传染病学会-西班牙移植感染研究与协作组-感染病协作组(SEIMC-GESITRA-IC)的研究
Infection. 2025 Sep 1. doi: 10.1007/s15010-025-02625-6.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
6
Antifungal agents for preventing fungal infections in solid organ transplant recipients.用于预防实体器官移植受者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2004(3):CD004291. doi: 10.1002/14651858.CD004291.pub2.
7
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis.预防实体器官移植后结核病的抗生素预防措施。
Cochrane Database Syst Rev. 2014 Mar 4;2014(3):CD008597. doi: 10.1002/14651858.CD008597.pub2.
8
Ophthalmia Neonatorum新生儿眼炎
9
Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis.抗病毒预防对实体器官移植受者EBV病毒血症及移植后淋巴细胞增生性疾病的影响:一项系统评价与荟萃分析
Virol J. 2025 Jan 15;22(1):11. doi: 10.1186/s12985-025-02623-y.
10
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.用于预防非中性粒细胞减少的重症患者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3.

本文引用的文献

1
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.全球隐球菌病诊断和管理指南:欧洲癌症研究与治疗组织和国际系统性真菌感染学会与美国微生物学会合作开展的一项倡议。
Lancet Infect Dis. 2024 Aug;24(8):e495-e512. doi: 10.1016/S1473-3099(23)00731-4. Epub 2024 Feb 9.
2
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).血液恶性肿瘤患者侵袭性真菌病的一级预防:德国血液学和肿瘤内科学会(DGHO)传染病工作组(AGIHO)的建议 2022 年更新版。
J Antimicrob Chemother. 2023 Aug 2;78(8):1813-1826. doi: 10.1093/jac/dkad143.
3
Antifungal prophylaxis and pre-emptive therapy: When and how?抗真菌预防和先发治疗:何时及如何应用?
Mol Aspects Med. 2023 Aug;92:101190. doi: 10.1016/j.mam.2023.101190. Epub 2023 May 17.
4
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM).亚太地区实验室真菌学的现状:来自欧洲医学真菌学联盟(ECMM)和国际人类与动物真菌学会(ISHAM)的调查。
Int J Antimicrob Agents. 2023 Mar;61(3):106718. doi: 10.1016/j.ijantimicag.2023.106718. Epub 2023 Jan 12.
5
The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.欧洲实验室真菌学现状及抗真菌治疗可及性:欧洲医学真菌学联合会调查
Lancet Microbe. 2023 Jan;4(1):e47-e56. doi: 10.1016/S2666-5247(22)00261-0. Epub 2022 Dec 1.
6
The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey.非洲临床真菌学现状:欧洲医学真菌学联合会和国际人类与动物真菌学会调查。
Lancet Microbe. 2022 Jun;3(6):e464-e470. doi: 10.1016/S2666-5247(21)00190-7. Epub 2022 Jan 18.
7
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM.全球罕见酵母感染诊断与管理指南:由欧洲癌症研究与治疗组织(ECMM)联合国际临床微生物学与感染病学会(ISHAM)和美国微生物学会(ASM)共同发起。
Lancet Infect Dis. 2021 Dec;21(12):e375-e386. doi: 10.1016/S1473-3099(21)00203-6. Epub 2021 Aug 19.
8
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology.全球地方性真菌病诊断和管理指南:由欧洲医学真菌学联合会与国际人类与动物真菌学会合作发起。
Lancet Infect Dis. 2021 Dec;21(12):e364-e374. doi: 10.1016/S1473-3099(21)00191-2. Epub 2021 Aug 6.
9
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.实体器官移植患者侵袭性曲霉菌病:诊断、预防、治疗和反应评估。
BMC Infect Dis. 2021 Mar 24;21(1):296. doi: 10.1186/s12879-021-05958-3.
10
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.罕见霉菌感染诊断与管理全球指南:欧洲医学真菌学联合会与国际人类与动物真菌学会及美国微生物学会合作发起
Lancet Infect Dis. 2021 Aug;21(8):e246-e257. doi: 10.1016/S1473-3099(20)30784-2. Epub 2021 Feb 16.